| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Common Stock | Award | $19.8K | +296 | +6.48% | $66.76 | 4.86K | May 17, 2021 | Direct | F1 |
| transaction | TNDM | Common Stock | Options Exercise | $17.9K | +243 | +121.5% | $73.73 | 443 | May 18, 2021 | Berger Family Trust | F2, F3 |
| transaction | TNDM | Common Stock | Sale | -$17.9K | -201 | -45.37% | $89.14 | 242 | May 18, 2021 | Berger Family Trust | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNDM | Restricted Stock Unit | Award | $0 | +2.6K | $0.00 | 2.6K | May 18, 2021 | Common Stock | 2.6K | Direct | F4, F5, F6 | ||
| transaction | TNDM | Performance Stock Unit | Award | $0 | +2.6K | $0.00 | 2.6K | May 18, 2021 | Common Stock | 2.6K | Direct | F4, F7 | ||
| transaction | TNDM | Stock Option | Award | $0 | +7.94K | $0.00 | 7.94K | May 18, 2021 | Common Stock | 7.94K | $81.63 | Direct | F4, F8, F9 | |
| transaction | TNDM | Warrant | Options Exercise | $17.9K | +243 | $73.73 | 0 | May 18, 2021 | Common Stock | 243 | $73.73 | See Footnote | F3, F10 |
| Id | Content |
|---|---|
| F1 | The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c). |
| F2 | The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. |
| F3 | The securities are held by the Berger Family Trust dated April 16, 2008. |
| F4 | Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). |
| F5 | Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. |
| F6 | RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. |
| F7 | Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. |
| F8 | The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan. |
| F9 | The expiration date for these options is 10 years from the date of grant. |
| F10 | The expiration dates for these warrants are August 31, 2021 (135 shares), July 3, 2022 (54 shares) and August 21, 2022 (54 shares). |